Dental opioid prescribing rates after the up-scheduling of codeine in Australia
L Teoh, S Hollingworth, R Marino, MJ McCullough
Scientific Reports | NATURE PUBLISHING GROUP | Published : 2020
The misuse of pharmaceutical opioids is a major public health issue. In Australia, codeine was re-scheduled on 1 February 2018 to restrict access; it is now only available on prescription. The aim of this study was to measure the change in dental opioid prescriptions, one year before and after the codeine re-scheduling in Australia and to assess dental prescribing rates of opioids for 2018 by population and by clinician. Data was extracted for dental opioids for the year immediately prior and after the codeine up-schedule (1 February 2017-31 January 2019) from the publicly-available national prescription database (Pharmaceutical Benefits Scheme). Descriptive statistics, T-tests and odds rati..View full abstract
Awarded by Australian Government Research Training Program Scholarship
This research was supported by the Australian Government Research Training Program Scholarship (no. 241616) (LT).